Global Small Interfering RNA (siRNA) Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Small Interfering RNA (siRNA) Therapeutics market size will reach US$ million by 2031.
Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Small Interfering RNA (siRNA) Therapeutics Industry Forecast” looks at past sales and reviews total world Small Interfering RNA (siRNA) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Interfering RNA (siRNA) Therapeutics sales for 2025 through 2031. With Small Interfering RNA (siRNA) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Interfering RNA (siRNA) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Small Interfering RNA (siRNA) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Interfering RNA (siRNA) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Interfering RNA (siRNA) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Interfering RNA (siRNA) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Interfering RNA (siRNA) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Small Interfering RNA (siRNA) Therapeutics Industry Forecast” looks at past sales and reviews total world Small Interfering RNA (siRNA) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Interfering RNA (siRNA) Therapeutics sales for 2025 through 2031. With Small Interfering RNA (siRNA) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Interfering RNA (siRNA) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Small Interfering RNA (siRNA) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Interfering RNA (siRNA) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Interfering RNA (siRNA) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Interfering RNA (siRNA) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Interfering RNA (siRNA) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Liposome Based Systemic Therapy
- Nanoparticle Based Systemic Therapy
- Other
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE
- Horizon Discovery
- Thermo Scientific
- OPKO Health
- AInylam Pharmaceuticals
- Arrowhead Research
- Sanofi Genzyme
- Genecon Biotechnologies
- Arbutus Biopharma
- Silent Therapeutics
- Sylentis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (2020-2031)
2.1.2 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Small Interfering RNA (siRNA) Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Type
2.2.1 Liposome Based Systemic Therapy
2.2.2 Nanoparticle Based Systemic Therapy
2.2.3 Other
2.3 Small Interfering RNA (siRNA) Therapeutics Market Size by Type
2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Small Interfering RNA (siRNA) Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Small Interfering RNA (siRNA) Therapeutics Market Size by Application
2.5.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Player
3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS BY REGION
4.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.4 APAC Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.5 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025)
5.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
5.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025)
6.2 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
6.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast
10.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.2 Canada Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.3 Mexico Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.4 Brazil Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.3.1 China Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.2 Japan Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.3 Korea Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.4 Southeast Asia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.5 India Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.6 Australia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.2 France Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.3 UK Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.4 Italy Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.5 Russia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.2 South Africa Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.3 Israel Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.4 Turkey Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.6 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Type (2026-2031)
10.7 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Small Interfering RNA (siRNA) Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 GE
11.1.1 GE Company Information
11.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Offered
11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GE Main Business Overview
11.1.5 GE Latest Developments
11.2 Horizon Discovery
11.2.1 Horizon Discovery Company Information
11.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Horizon Discovery Main Business Overview
11.2.5 Horizon Discovery Latest Developments
11.3 Thermo Scientific
11.3.1 Thermo Scientific Company Information
11.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Thermo Scientific Main Business Overview
11.3.5 Thermo Scientific Latest Developments
11.4 OPKO Health
11.4.1 OPKO Health Company Information
11.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 OPKO Health Main Business Overview
11.4.5 OPKO Health Latest Developments
11.5 AInylam Pharmaceuticals
11.5.1 AInylam Pharmaceuticals Company Information
11.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 AInylam Pharmaceuticals Main Business Overview
11.5.5 AInylam Pharmaceuticals Latest Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Information
11.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Arrowhead Research Main Business Overview
11.6.5 Arrowhead Research Latest Developments
11.7 Sanofi Genzyme
11.7.1 Sanofi Genzyme Company Information
11.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Genzyme Main Business Overview
11.7.5 Sanofi Genzyme Latest Developments
11.8 Genecon Biotechnologies
11.8.1 Genecon Biotechnologies Company Information
11.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Genecon Biotechnologies Main Business Overview
11.8.5 Genecon Biotechnologies Latest Developments
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Information
11.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Arbutus Biopharma Main Business Overview
11.9.5 Arbutus Biopharma Latest Developments
11.10 Silent Therapeutics
11.10.1 Silent Therapeutics Company Information
11.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Silent Therapeutics Main Business Overview
11.10.5 Silent Therapeutics Latest Developments
11.11 Sylentis
11.11.1 Sylentis Company Information
11.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sylentis Main Business Overview
11.11.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (2020-2031)
2.1.2 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Small Interfering RNA (siRNA) Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Type
2.2.1 Liposome Based Systemic Therapy
2.2.2 Nanoparticle Based Systemic Therapy
2.2.3 Other
2.3 Small Interfering RNA (siRNA) Therapeutics Market Size by Type
2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Small Interfering RNA (siRNA) Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Small Interfering RNA (siRNA) Therapeutics Market Size by Application
2.5.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Player
3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS BY REGION
4.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.4 APAC Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.5 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025)
5.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
5.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025)
6.2 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
6.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast
10.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.2 Canada Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.3 Mexico Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.2.4 Brazil Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.3.1 China Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.2 Japan Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.3 Korea Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.4 Southeast Asia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.5 India Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.3.6 Australia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.2 France Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.3 UK Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.4 Italy Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.4.5 Russia Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.2 South Africa Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.3 Israel Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.5.4 Turkey Market Small Interfering RNA (siRNA) Therapeutics Forecast
10.6 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Type (2026-2031)
10.7 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Small Interfering RNA (siRNA) Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 GE
11.1.1 GE Company Information
11.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Offered
11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GE Main Business Overview
11.1.5 GE Latest Developments
11.2 Horizon Discovery
11.2.1 Horizon Discovery Company Information
11.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Horizon Discovery Main Business Overview
11.2.5 Horizon Discovery Latest Developments
11.3 Thermo Scientific
11.3.1 Thermo Scientific Company Information
11.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Thermo Scientific Main Business Overview
11.3.5 Thermo Scientific Latest Developments
11.4 OPKO Health
11.4.1 OPKO Health Company Information
11.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 OPKO Health Main Business Overview
11.4.5 OPKO Health Latest Developments
11.5 AInylam Pharmaceuticals
11.5.1 AInylam Pharmaceuticals Company Information
11.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 AInylam Pharmaceuticals Main Business Overview
11.5.5 AInylam Pharmaceuticals Latest Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Information
11.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Arrowhead Research Main Business Overview
11.6.5 Arrowhead Research Latest Developments
11.7 Sanofi Genzyme
11.7.1 Sanofi Genzyme Company Information
11.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Genzyme Main Business Overview
11.7.5 Sanofi Genzyme Latest Developments
11.8 Genecon Biotechnologies
11.8.1 Genecon Biotechnologies Company Information
11.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Genecon Biotechnologies Main Business Overview
11.8.5 Genecon Biotechnologies Latest Developments
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Information
11.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Arbutus Biopharma Main Business Overview
11.9.5 Arbutus Biopharma Latest Developments
11.10 Silent Therapeutics
11.10.1 Silent Therapeutics Company Information
11.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Silent Therapeutics Main Business Overview
11.10.5 Silent Therapeutics Latest Developments
11.11 Sylentis
11.11.1 Sylentis Company Information
11.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sylentis Main Business Overview
11.11.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Small Interfering RNA (siRNA) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposome Based Systemic Therapy
Table 4. Major Players of Nanoparticle Based Systemic Therapy
Table 5. Major Players of Other
Table 6. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
Table 15. Small Interfering RNA (siRNA) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Therapeutics
Table 40. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Therapeutics
Table 41. Key Industry Trends of Small Interfering RNA (siRNA) Therapeutics
Table 42. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GE Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 47. GE Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 48. GE Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GE Main Business
Table 50. GE Latest Developments
Table 51. Horizon Discovery Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 52. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 53. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Horizon Discovery Main Business
Table 55. Horizon Discovery Latest Developments
Table 56. Thermo Scientific Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 57. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 58. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Thermo Scientific Main Business
Table 60. Thermo Scientific Latest Developments
Table 61. OPKO Health Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 62. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 63. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. OPKO Health Main Business
Table 65. OPKO Health Latest Developments
Table 66. AInylam Pharmaceuticals Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 67. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 68. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. AInylam Pharmaceuticals Main Business
Table 70. AInylam Pharmaceuticals Latest Developments
Table 71. Arrowhead Research Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 72. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 73. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Arrowhead Research Main Business
Table 75. Arrowhead Research Latest Developments
Table 76. Sanofi Genzyme Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 77. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 78. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sanofi Genzyme Main Business
Table 80. Sanofi Genzyme Latest Developments
Table 81. Genecon Biotechnologies Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 82. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 83. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Genecon Biotechnologies Main Business
Table 85. Genecon Biotechnologies Latest Developments
Table 86. Arbutus Biopharma Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 87. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 88. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Arbutus Biopharma Main Business
Table 90. Arbutus Biopharma Latest Developments
Table 91. Silent Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 92. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 93. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Silent Therapeutics Main Business
Table 95. Silent Therapeutics Latest Developments
Table 96. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 97. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 98. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Sylentis Main Business
Table 100. Sylentis Latest Developments
Table 1. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Small Interfering RNA (siRNA) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposome Based Systemic Therapy
Table 4. Major Players of Nanoparticle Based Systemic Therapy
Table 5. Major Players of Other
Table 6. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
Table 15. Small Interfering RNA (siRNA) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Therapeutics
Table 40. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Therapeutics
Table 41. Key Industry Trends of Small Interfering RNA (siRNA) Therapeutics
Table 42. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GE Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 47. GE Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 48. GE Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GE Main Business
Table 50. GE Latest Developments
Table 51. Horizon Discovery Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 52. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 53. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Horizon Discovery Main Business
Table 55. Horizon Discovery Latest Developments
Table 56. Thermo Scientific Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 57. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 58. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Thermo Scientific Main Business
Table 60. Thermo Scientific Latest Developments
Table 61. OPKO Health Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 62. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 63. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. OPKO Health Main Business
Table 65. OPKO Health Latest Developments
Table 66. AInylam Pharmaceuticals Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 67. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 68. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. AInylam Pharmaceuticals Main Business
Table 70. AInylam Pharmaceuticals Latest Developments
Table 71. Arrowhead Research Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 72. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 73. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Arrowhead Research Main Business
Table 75. Arrowhead Research Latest Developments
Table 76. Sanofi Genzyme Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 77. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 78. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sanofi Genzyme Main Business
Table 80. Sanofi Genzyme Latest Developments
Table 81. Genecon Biotechnologies Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 82. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 83. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Genecon Biotechnologies Main Business
Table 85. Genecon Biotechnologies Latest Developments
Table 86. Arbutus Biopharma Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 87. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 88. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Arbutus Biopharma Main Business
Table 90. Arbutus Biopharma Latest Developments
Table 91. Silent Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 92. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 93. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Silent Therapeutics Main Business
Table 95. Silent Therapeutics Latest Developments
Table 96. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 97. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 98. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Sylentis Main Business
Table 100. Sylentis Latest Developments
LIST OF FIGURES
Figure 1. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Small Interfering RNA (siRNA) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2024
Figure 10. Small Interfering RNA (siRNA) Therapeutics in Hospital
Figure 11. Global Small Interfering RNA (siRNA) Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Small Interfering RNA (siRNA) Therapeutics in Research Institutions
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market: Research Institutions (2020-2025) & ($ millions)
Figure 14. Small Interfering RNA (siRNA) Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 16. Small Interfering RNA (siRNA) Therapeutics in Academic Institutions
Figure 17. Global Small Interfering RNA (siRNA) Therapeutics Market: Academic Institutions (2020-2025) & ($ millions)
Figure 18. Small Interfering RNA (siRNA) Therapeutics in Other
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2024
Figure 21. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player in 2024
Figure 22. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas Small Interfering RNA (siRNA) Therapeutics Value Market Share by Country in 2024
Figure 28. United States Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 33. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 34. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 42. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 43. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. France Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. China Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. India Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. France Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Small Interfering RNA (siRNA) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2024
Figure 10. Small Interfering RNA (siRNA) Therapeutics in Hospital
Figure 11. Global Small Interfering RNA (siRNA) Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Small Interfering RNA (siRNA) Therapeutics in Research Institutions
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market: Research Institutions (2020-2025) & ($ millions)
Figure 14. Small Interfering RNA (siRNA) Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 16. Small Interfering RNA (siRNA) Therapeutics in Academic Institutions
Figure 17. Global Small Interfering RNA (siRNA) Therapeutics Market: Academic Institutions (2020-2025) & ($ millions)
Figure 18. Small Interfering RNA (siRNA) Therapeutics in Other
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2024
Figure 21. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player in 2024
Figure 22. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas Small Interfering RNA (siRNA) Therapeutics Value Market Share by Country in 2024
Figure 28. United States Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2024
Figure 33. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 34. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2024
Figure 42. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 43. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. France Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. China Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. India Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. France Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Plant Tissue Culture Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
85 pages
Global Interferon Alpha-2a Biosimilar Market Growth 2025-2031
US$ 3,660.00
March 2025
93 pages
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
175 pages
